These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22288296)

  • 1. Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial.
    Cağlar N; Dincer I
    Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1359-68. PubMed ID: 22288296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
    Galetta F; Franzoni F; Magagna A; Femia FR; Pentimone F; Santoro G; Carpi A
    Biomed Pharmacother; 2005; 59(1-2):15-9. PubMed ID: 15740930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy.
    Seeman T; Gilík J; Vondrák K; Simková E; Flögelová H; Hladíková M; Janda J
    Am J Hypertens; 2007 Sep; 20(9):990-6. PubMed ID: 17765141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.
    Gosse P; Sheridan DJ; Zannad F; Dubourg O; Guéret P; Karpov Y; de Leeuw PW; Palma-Gamiz JL; Pessina A; Motz W; Degaute JP; Chastang C
    J Hypertens; 2000 Oct; 18(10):1465-75. PubMed ID: 11057435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of spironolactone-altizide on left ventricular hypertrophy.
    Degre S; Detry JM; Unger P; Cosyns J; Brohet C; Kormoss N
    Acta Cardiol; 1998; 53(5):261-7. PubMed ID: 9922803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
    J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy.
    Fogari R; Zoppi A; Mugellini A; Maffioli P; Preti P; Derosa G
    Expert Opin Pharmacother; 2012 Jun; 13(8):1091-9. PubMed ID: 22515416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients.
    Scaglione R; Argano C; Di Chiara T; Parrinello G; Colomba D; Avellone G; Donatelli M; Corrao S; Licata G
    J Hum Hypertens; 2007 Apr; 21(4):307-15. PubMed ID: 17301824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension.
    Galderisi M; D'Errico A; Sidiropulos M; Innelli P; de Divitiis O; de Simone G
    J Hypertens; 2009 Oct; 27(10):2108-15. PubMed ID: 19564794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan.
    Fountoulaki K; Dimopoulos V; Giannakoulis J; Zintzaras E; Triposkiadis F
    Am J Hypertens; 2005 Feb; 18(2 Pt 1):171-7. PubMed ID: 15752943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients.
    Nielsen FS; Sato A; Ali S; Tarnow L; Smidt UM; Kastrup J; Parving HH
    Diabetes Care; 1998 May; 21(5):804-9. PubMed ID: 9589245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
    Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
    Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
    Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
    Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients.
    Yilmaz R; Altun B; Kahraman S; Ozer N; Akinci D; Turgan C
    Ren Fail; 2010; 32(8):903-12. PubMed ID: 20722555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
    Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
    Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.
    Lonn E; Shaikholeslami R; Yi Q; Bosch J; Sullivan B; Tanser P; Magi A; Yusuf S
    J Am Coll Cardiol; 2004 Jun; 43(12):2200-6. PubMed ID: 15193680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of delapril in combination with indapamide on blood pressure and left ventricular mass in elderly hypertensive patients.
    Acanfora D; Lowenthal DT; Furgi G; Trojano L; Picone C; Nicolino A; Iannuzzi GL; Papa A; Rengo F
    Am J Ther; 1998 Jan; 5(1):17-23. PubMed ID: 10099033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.